A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
Clinical trial NCT02981342 · COMPLETED
Trial details
- NCT number
- NCT02981342
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2018-04-20
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.